Cost Implication of Inappropriate Empiric Antibiotics in Gram-Negative Infections
Hosp Pharm
.
2024 Dec 12:00185787241303035.
doi: 10.1177/00185787241303035.
Online ahead of print.
Authors
Paul Juang
1
,
Parker Lindsey
1
,
Scott T Micek
1
,
Marin H Kollef
2
Affiliations
1
Department of Pharmacy Practice, University of Health Sciences and Pharmacy, St. Louis, MO, USA.
2
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
PMID:
39677556
PMCID:
PMC11635783
DOI:
10.1177/00185787241303035
No abstract available